
ABBV+25.84%9.1%

AMGN+49.57%9.1%

BMY+39.84%9.1%

DHR+3.33%9.1%

IQV+35.92%9.1%

NVO-17.97%9.1%

RGEN+45.15%9.1%

SRT3.XETRA+25.54%9.1%

TECH+26.68%9.1%

WAT+35.91%9.1%

ZLAB-25.77%9.1%
As of Aug 24, 2026, 4:53 AM ET
MedTech Short '25: Heavy China Exposure Constituents
AbbVie Inc.ABBV | 9.1% | 1.21% | 5.97% | 2.18% | 5.61% | 15.98% | 14.19% | 29.15% | 36.48% | 154.13% | 25.84% | $468.13B |
Amgen Inc.AMGN | 9.1% | 1.29% | 6.04% | 16.83% | 14.06% | 34.22% | 13.18% | 43.71% | 34.68% | 115.89% | 49.57% | $237.11B |
Bio-Techne CorporationTECH | 9.1% | 0.06% | 0.24% | 1.01% | 0.32% | 22.97% | 22.58% | 23.88% | 0.27% | -38.63% | 26.68% | $11.32B |
Bristol-Myers Squibb CompanyBMY | 9.1% | 2.35% | 5.35% | 7.92% | 2.60% | 24.23% | 7.44% | 13.65% | 42.40% | 11.14% | 39.84% | $136.88B |
Danaher CorporationDHR | 9.1% | 1.36% | 5.50% | 13.69% | 12.24% | -4.40% | 3.90% | 6.67% | -18.61% | -21.43% | 3.33% | $153.85B |
IQVIA Holdings Inc.IQV | 9.1% | 1.47% | 6.55% | 24.88% | 10.55% | 15.27% | 45.31% | 49.00% | 4.37% | 2.14% | 35.92% | $42.77B |
Novo Nordisk A/SNVO | 9.1% | 1.30% | -0.91% | -4.16% | -0.72% | -8.14% | 24.81% | -31.51% | -65.88% | -8.31% | -17.97% | $207.55B |
Repligen CorporationRGEN | 9.1% | 0.47% | 9.93% | 37.26% | 28.45% | 10.54% | 40.71% | 38.35% | 23.39% | -31.93% | 45.15% | $10.22B |
Sartorius AGSRT3.XETRA | 9.1% | -0.84% | 4.80% | 14.73% | 14.69% | -0.77% | 1.60% | 22.82% | 6.91% | -56.86% | 25.54% | $19.91B |
Waters CorporationWAT | 9.1% | 1.49% | -1.04% | 9.61% | 8.85% | 8.13% | 28.59% | 13.25% | 19.94% | 1.97% | 35.91% | $30.72B |
Zai Lab LimitedZLAB | 9.1% | -0.04% | 0.04% | 35.33% | 42.36% | 47.45% | 35.33% | -28.60% | 44.34% | -82.00% | -25.77% | $2.94B |
| Theme return | — | -0.92% | -3.86% | -15.27% | -12.41% | -18.51% | -24.10% | -22.10% | -17.48% | -12.33% | -29.02% | — |
| Average | 9.1% | 0.92% | 3.86% | 14.48% | 12.64% | 15.04% | 21.60% | 16.40% | 11.66% | 4.19% | 22.19% | $120.13B |
| Median | 9.1% | 1.29% | 5.35% | 13.69% | 10.55% | 15.27% | 22.58% | 22.82% | 19.94% | -8.31% | 26.68% | $42.77B |
| Std Dev | 0.0% | 0.86% | 3.48% | 12.85% | 12.21% | 15.95% | 14.19% | 25.19% | 30.89% | 67.50% | 23.89% | $136.69B |
| Min | 9.1% | -0.84% | -1.04% | -4.16% | -0.72% | -8.14% | 1.60% | -31.51% | -65.88% | -82.00% | -25.77% | $2.94B |
| Max | 9.1% | 2.35% | 9.93% | 37.26% | 42.36% | 47.45% | 45.31% | 49.00% | 44.34% | 154.13% | 49.57% | $468.13B |
| % Positive Tickers | 81.82% | 81.82% | 90.91% | 90.91% | 72.73% | 100.00% | 81.82% | 81.82% | 45.45% | 81.82% |
About this theme
MedTech Short '25: Heavy China Exposure tracks 11 publicly listed stocks in this theme: ABBV, AMGN, BMY, DHR, IQV, NVO, RGEN, SRT3.XETRA, TECH, WAT, ZLAB. See the constituent table for details.
